iSpeak Blog
2020 ISPE APAC Pharma Manufacturing Virtual Conference
Thank You for Making this Virtual Conference& Executive Forum a Huge Success!
The 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum delivered engaging presentations and case studies on cutting-edge topics with many opportunities to gain insights from top industry professionals. Check out the content below to get insights from the conference. Access to presentations for registered attendees.
On Demand Sessions
If you missed the 2020 ISPE Asia Pacific Pharmaceutical Manufacturing Virtual Conference & Executive Forum, this is your opportunity to gain access to all of the educational content from the conference and view it on your own schedule. This conference focused on emerging supply chain, quality, and compliance challenges in light of COVID-19. In addition, regulatory leaders shared best practices for assessing critical manufacturing processes and lessons learned to improve and sustain a reliable supply of quality medicine.
Cleaning Validation and Cross Contamination Control
Dr. Ranjana Pathak, President-Global Quality, Medical Affairs & Pharmacovigilance, Cipla, shared lessons learned in the cleaning validation process during the 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum. In this clip, she takes a look at standard operating procedures (SOPs) and stresses the importance of assigning responsibilities.
Executive Forum: Case Study Report-Outs and Panel Discussion - Part 4
Get a taste of the compelling case study group discussions from the 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum! In this clip, program committee member Deva H. Puranam, Head of Global Quality Investigations, Mylan, reports out from Case Study 4 Drug Shortage Scenario: Managing an organization with multiple sites operating at different levels of quality systems maturity.
2020 APAC Supply Chain and OOS Q&A Discussion
Should a firm notify the FDA if they stop manufacturing a product (not on the drug shortage list) due to compliance or scientific-related issues? Program Co-Chair Frances Marie Zipp posed this question to the panel during the Supply Chain and OOS Q&A Discussion at the 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum.
Watch this clip to hear what Jila Breeze, SVP, Global Head Quality & Compliance, SUN PHARMA, had to say.
2020 APAC OOS Investigations
Why do Out-of-Specifications (OOS) investigations continue to be a challenge in the pharmaceutical industry? We explored this today during the 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum. In this clip, Jila Breeze, SVP, Global Head Quality & Compliance, SUN PHARMA, touches on regulatory requirements and historical data for Out-of-Specifications.
2020 APAC Conference Executive Forum Part1: Freight Logistics
Watch Now: In this clip from the 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum, Rajiv Malik, President, Mylan, focuses on how COVID-19 has impacted freight and logistics and how Mylan has overcome such challenges during his presentation “Supply Chain Security in Times of Crisis.”
2020 APAC Conference Executive Forum Part1: Ancillary Vendor Disruption
During the 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum, Johnny Mikell, Head of Global Quality, Lupin Pharmaceuticals, offered insights into the impact of COVID-19 on the pharmaceutical supply chain. Watch this clip to hear him touch on challenges for the ancillary industry and the disruption in vendor support.
